Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07429643 | Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer. | not yet recruiting | Phase 2 / Phase 3 | 20 | Assiut UniversityOTHER | 0 | Feb 24, 2026 | clinicaltrials |
| NCT06958224 | Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers(ESCAT) | not yet recruiting | N/A | 360 | University Hospital, LilleOTHER | 0 | Feb 20, 2026 |
| clinicaltrials |
| NCT07422103 | PAN-CLO-BU (PANcreas-CLOstridium-BUtyricum)(PAN-CLO-BU) | not yet recruiting | N/A | 158 | Casa di Cura Dott. PederzoliOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT07415525 | IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer | not yet recruiting | Phase 2 | 40 | Zhejiang UniversityOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06615830 | Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer. | not yet recruiting | — | 185 | Prof. Dr. med. Dres. h.c. Jan Schmidt, MMEOTHER | 0 | Feb 11, 2026 | clinicaltrials |
| NCT07394205 | Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer | not yet recruiting | Early Phase 1 | 18 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT06203821 | Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer | not yet recruiting | Phase 1 | 25 | Aram HezelOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07383922 | A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer | not yet recruiting | Phase 3 | 524 | FutureGen Biopharmaceutical (Beijing) Co., LtdINDUSTRY | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07368218 | Comparison of Transmesocolic Versus Retromesenteric Reconstruction in Cephalic Duodenopancreatectomy (FAST Trial)(FAST) | not yet recruiting | N/A | 124 | Hospital Universitari de BellvitgeOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT07353827 | FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma | not yet recruiting | Phase 2 | 36 | Sun Yat-sen UniversityOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT07326189 | Preoperative Right Hepatic Artery Embolization for Locally Advanced Bismuth IIIb and IV Perihilar Cholangiocarcinoma(PHAE-PHCC) | not yet recruiting | N/A | 33 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jan 16, 2026 | clinicaltrials |
| NCT07348107 | ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.(ATARI-PDAC) | not yet recruiting | Phase 1 | 10 | Daniel BreadnerOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT07344116 | Hepatobiliary and Pancreatic Tumor Biobank | not yet recruiting | — | 300 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Jan 15, 2026 | clinicaltrials |
| NCT07328919 | Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations | not yet recruiting | Phase 3 | 138 | TransThera Sciences (Nanjing), Inc.INDUSTRY | 1 | Jan 9, 2026 | clinicaltrials |
| NCT07311798 | Impact of Vascular Resection on Survival and Postoperative Outcomes in Patients With Hilar Cholangiocarcinoma: A Retrospective Study | not yet recruiting | — | 300 | Yongjun ChenOTHER | 0 | Dec 31, 2025 | clinicaltrials |
| NCT07301229 | A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer | not yet recruiting | Phase 2 | 100 | Shanghai Henlius BiotechINDUSTRY | 0 | Dec 24, 2025 | clinicaltrials |
| NCT07296666 | Adjuvant Chemotherapy for BTC Based on 3D-PTA | not yet recruiting | Phase 2 | 98 | Fudan UniversityOTHER | 0 | Dec 22, 2025 | clinicaltrials |
| NCT07272109 | Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes(PTCA199-16) | not yet recruiting | Phase 3 | 210 | Fudan UniversityOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT07277452 | Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic Cancer(NOTABLE-309) | not yet recruiting | Phase 2 | 156 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT05453851 | A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors | not yet recruiting | Phase 1 / Phase 2 | 12 | OHSU Knight Cancer InstituteOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT07242911 | Study on Efficacy and Safety of VMAT Technique With Local Dose Escalation for Unresectable Pancreatic Cancer | not yet recruiting | — | 30 | Chifeng Tumor HospitalOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT06177522 | Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer | not yet recruiting | Phase 2 | 30 | Jinling Hospital, ChinaOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07233850 | A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers | not yet recruiting | Phase 2 | 300 | Shenyang Sunshine Pharmaceutical Co., LTD.INDUSTRY | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07208526 | A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST | not yet recruiting | N/A | 270 | Shanghai Zhongshan HospitalOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT07208539 | AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.(ZSPAC-14) | not yet recruiting | Phase 2 | 77 | Shanghai Zhongshan HospitalOTHER | 0 | Oct 6, 2025 | clinicaltrials |
| NCT07198321 | A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 450 | Genfleet Therapeutics (Shanghai) Inc.INDUSTRY | 1 | Sep 30, 2025 | clinicaltrials |
| NCT07176052 | Expectation, Pain Outcomes, and Pain Medication Following Oncology Abdominal Surgery: A Cohort Study | not yet recruiting | — | 200 | Rigshospitalet, DenmarkOTHER | 0 | Sep 16, 2025 | clinicaltrials |
| NCT07172503 | Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors | not yet recruiting | N/A | 56 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07160283 | The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer | not yet recruiting | Phase 2 | 96 | The Second Affiliated Hospital of Shandong First Medical UniversityOTHER | 0 | Sep 8, 2025 | clinicaltrials |
| NCT07153289 | CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)(ResCPa) | not yet recruiting | Phase 1 / Phase 2 | 38 | University Hospital TuebingenOTHER | 0 | Sep 3, 2025 | clinicaltrials |
| NCT07149558 | Volume-Restricted Resection for Perihilar Cholangiocarcinoma | not yet recruiting | — | 300 | Yongjun ChenOTHER | 0 | Sep 2, 2025 | clinicaltrials |
| NCT07132060 | MRI-guided Dose Intensification Program Locally Advanced Pancreatic Cancer | not yet recruiting | N/A | 30 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 0 | Aug 27, 2025 | clinicaltrials |
| NCT07138976 | EUS- and US- Guided Biopsy for Pancreatic Lesion | not yet recruiting | — | 2,517 | Tian'an JiangOTHER | 0 | Aug 24, 2025 | clinicaltrials |
| NCT07128290 | PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma(PEHRICCA) | not yet recruiting | Phase 2 | 49 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT07114666 | XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer | not yet recruiting | N/A | 12 | Peking Union Medical College HospitalOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07026981 | [Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers | not yet recruiting | Early Phase 1 | 12 | Qiubai LiOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT06196671 | Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer(PTCA199-8) | not yet recruiting | Phase 2 | 30 | Fudan UniversityOTHER | 0 | Aug 7, 2025 | clinicaltrials |
| NCT07095621 | Feasibility and Effectiveness of Three-day Discharge After Distal Pancreatectomy(3DD) | not yet recruiting | — | 35 | IRCCS San RaffaeleOTHER | 0 | Aug 7, 2025 | clinicaltrials |
| NCT07108504 | Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer | not yet recruiting | Phase 2 | 30 | Shanghai Zhongshan HospitalOTHER | 0 | Aug 7, 2025 | clinicaltrials |
| NCT07097064 | Evaluation of the Stereotactic MR-guided Adaptive Radiotherapy for Locally Advanced Pancreatic Cancers(RAIPANC) | not yet recruiting | Phase 2 | 160 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT07093593 | Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs(RAMA) | not yet recruiting | N/A | 260 | Centre Georges Francois LeclercOTHER | 0 | Jul 30, 2025 | clinicaltrials |
| NCT07087392 | Inverted-Ω Anastomosis in Laparoscopic Duodenum-Preserving Pancreatic Head Resection or Laparoscopic Central Pancreatectomy | not yet recruiting | N/A | 20 | West China HospitalOTHER | 1 | Jul 28, 2025 | clinicaltrials |
| NCT06541561 | Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Pancreatectomy | not yet recruiting | N/A | 132 | West China HospitalOTHER | 0 | Jul 17, 2025 | clinicaltrials |
| NCT07062328 | A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC(HP-BTC-002) | not yet recruiting | Phase 2 | 39 | Sun Yat-sen UniversityOTHER | 0 | Jul 14, 2025 | clinicaltrials |
| NCT07064447 | Spanish Registry of Direct Cholangiopancreatoscopy by Single Operator | not yet recruiting | — | 260 | Germans Trias i Pujol HospitalOTHER | 0 | Jul 14, 2025 | clinicaltrials |
| NCT07055568 | A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer | not yet recruiting | N/A | 18 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Jul 9, 2025 | clinicaltrials |
| NCT07056972 | Surveillance Discontinuation in 5 Year Stable Trivial Branch Duct Intraductal Papillary Mucinous Neoplasms(TRIVIAL) | not yet recruiting | — | 394 | Azienda Ospedaliera di PadovaOTHER | 0 | Jul 9, 2025 | clinicaltrials |
| NCT07012694 | 22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions | not yet recruiting | N/A | 576 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT06780553 | Validation of the Proteomic Profiling as a Diagnostic Test for Extra-hepatic Cholangiocarcinoma(PROFI-CHOL) | not yet recruiting | — | 60 | University Hospital, BordeauxOTHER | 1 | Jun 29, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Feb 24, 2026source: clinicaltrials